• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

计算化学、晶体学研究、取代 7-甲氧基吲哚嗪类似物的细胞毒性和抗结核活性。

Computational, crystallographic studies, cytotoxicity and anti-tubercular activity of substituted 7-methoxy-indolizine analogues.

机构信息

Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa, Kingdom of Saudi Arabia.

Department of Biotechnology and Food Technology, Durban University of Technology, Durban, South Africa.

出版信息

PLoS One. 2019 Jun 4;14(6):e0217270. doi: 10.1371/journal.pone.0217270. eCollection 2019.

DOI:10.1371/journal.pone.0217270
PMID:31163040
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6548424/
Abstract

Indolizines are heteroaromatic compounds, and their synthetic analogues have reportedly showed promising pharmacological properties. In this study, a series of synthetic 7-methoxy-indolizine derivatives were synthesised, characterised and evaluated for in vitro whole-cell anti-tuberculosis (TB) screening against susceptible (H37Rv) and multi-drug-resistant (MDR) strains of Mycobacterium tuberculosis (MTB) using the resazurin microplate assay method. The cytotoxicity was evaluated using the MTT assay. In silico molecular-docking study was conducted for compounds 5a-j against enoyl-[acyl-carrier] protein reductase, a key enzyme of the type II fatty acid synthesis that has attracted much interest for the development of novel anti-TB compounds. Thereafter, molecular dynamic (MD) simulation was undertaken for the most active inhibitors. Compounds 5i and 5j with the methoxy functional group at the meta position of the benzoyl group, which was at the third position of the indolizine nucleus, demonstrated encouraging anti-TB activity against MDR strains of MTB at 16 μg/mL. In silico studies showed binding affinity within the range of 7.07-8.57 kcal/mol, with 5i showing the highest binding affinity. Hydrogen bonding, π-π- interactions, and electrostatic interactions were common with the active site. Most of these interactions occurred with the catalytic amino acids (Pro193, Tyr158, Phe149, and Lys165). MD simulation showed that 5j possessed the highest binding affinity toward the enzyme, according to the two calculation methods (MM/PBSA and MM/GBSA). The single-crystal X-ray studies of compounds 5c and 5d revealed that the molecular arrangements in these two structures were mostly guided by C-H···O hydrogen-bonded dimeric motifs and C-H···N hydrogen bonds, while various secondary interactions (such as π···π and C-H···F) also contributed to crystal formation. Compounds 5a, 5c, 5i, and 5j exhibited no toxicity up to 500 μg/mL. In conclusion, 5i and 5j are promising anti-TB compounds that have shown high affinity based on docking and MD simulation results.

摘要

吲哚嗪是杂芳族化合物,其合成类似物据称表现出有前景的药理学特性。在这项研究中,合成了一系列合成的 7-甲氧基吲哚嗪衍生物,并通过使用 Resazurin 微量板测定法对体外全细胞抗结核(TB)筛选进行了评估,针对敏感(H37Rv)和多药耐药(MDR)结核分枝杆菌(MTB)菌株。使用 MTT 测定法评估细胞毒性。使用化合物 5a-j 对烯酰-[酰基载体]蛋白还原酶进行了计算机分子对接研究,烯酰-[酰基载体]蛋白还原酶是 II 型脂肪酸合成的关键酶,该酶因其对新型抗结核化合物的开发而备受关注。之后,对最活跃的抑制剂进行了分子动力学(MD)模拟。在吲哚嗪核的第三位置的苯甲酰基的间位具有甲氧基功能基团的化合物 5i 和 5j 对 16μg/mL 的 MDR 株 MTB 表现出令人鼓舞的抗结核活性。计算机研究表明,结合亲和力在 7.07-8.57 kcal/mol 范围内,其中 5i 表现出最高的结合亲和力。氢键、π-π-相互作用和静电相互作用与活性部位常见。大多数这些相互作用发生在催化氨基酸(Pro193、Tyr158、Phe149 和 Lys165)上。MD 模拟表明,根据两种计算方法(MM/PBSA 和 MM/GBSA),化合物 5j 对酶具有最高的结合亲和力。化合物 5c 和 5d 的单晶 X 射线研究表明,这两种结构中的分子排列主要受 C-H···O 氢键二聚体基序和 C-H···N 氢键的控制,而各种次级相互作用(如 π···π 和 C-H···F)也有助于晶体形成。化合物 5a、5c、5i 和 5j 在高达 500μg/mL 时没有表现出毒性。总之,5i 和 5j 是有前途的抗结核化合物,根据对接和 MD 模拟结果,它们表现出高亲和力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f330/6548424/b75a7fc417c3/pone.0217270.g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f330/6548424/e48ebc897125/pone.0217270.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f330/6548424/b8d50324b467/pone.0217270.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f330/6548424/ca706abe947f/pone.0217270.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f330/6548424/eb60ef334705/pone.0217270.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f330/6548424/b1fad807d94c/pone.0217270.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f330/6548424/d77015692378/pone.0217270.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f330/6548424/7dbb4da90e3c/pone.0217270.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f330/6548424/67d929d88fa2/pone.0217270.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f330/6548424/3d3f8f9110fc/pone.0217270.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f330/6548424/b75a7fc417c3/pone.0217270.g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f330/6548424/e48ebc897125/pone.0217270.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f330/6548424/b8d50324b467/pone.0217270.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f330/6548424/ca706abe947f/pone.0217270.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f330/6548424/eb60ef334705/pone.0217270.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f330/6548424/b1fad807d94c/pone.0217270.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f330/6548424/d77015692378/pone.0217270.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f330/6548424/7dbb4da90e3c/pone.0217270.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f330/6548424/67d929d88fa2/pone.0217270.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f330/6548424/3d3f8f9110fc/pone.0217270.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f330/6548424/b75a7fc417c3/pone.0217270.g010.jpg

相似文献

1
Computational, crystallographic studies, cytotoxicity and anti-tubercular activity of substituted 7-methoxy-indolizine analogues.计算化学、晶体学研究、取代 7-甲氧基吲哚嗪类似物的细胞毒性和抗结核活性。
PLoS One. 2019 Jun 4;14(6):e0217270. doi: 10.1371/journal.pone.0217270. eCollection 2019.
2
Molecular modeling studies and anti-TB activity of trisubstituted indolizine analogues; molecular docking and dynamic inputs.三取代吲嗪类似物的分子建模研究和抗结核活性;分子对接和动态输入。
J Biomol Struct Dyn. 2018 Jun;36(8):2163-2178. doi: 10.1080/07391102.2017.1345325. Epub 2017 Aug 14.
3
Identification of potent indolizine derivatives against Mycobacterial tuberculosis: In vitro anti-TB properties, in silico target validation, molecular docking and dynamics studies.鉴定具有抗结核分枝杆菌活性的吲哚嗪衍生物:体外抗结核特性、计算机靶点验证、分子对接和动力学研究。
Int J Biol Macromol. 2024 Aug;274(Pt 2):133285. doi: 10.1016/j.ijbiomac.2024.133285. Epub 2024 Jun 24.
4
Anti-tubercular activity and molecular docking studies of indolizine derivatives targeting mycobacterial InhA enzyme.针对分枝杆菌 InhA 酶的吲嗪衍生物的抗结核活性和分子对接研究。
J Enzyme Inhib Med Chem. 2021 Dec;36(1):1472-1487. doi: 10.1080/14756366.2021.1919889.
5
Synthesis and Structural Elucidation of Novel Benzothiazole Derivatives as Anti-tubercular Agents: In-silico Screening for Possible Target Identification.新型苯并噻唑衍生物作为抗结核药物的合成与结构解析:用于可能靶点识别的计算机模拟筛选
Med Chem. 2019;15(3):311-326. doi: 10.2174/1573406414666180703121815.
6
Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.新型吡唑啉类抗结核和细胞毒性药物的合成、生物学评价及分子对接研究
Infect Disord Drug Targets. 2019;19(3):310-321. doi: 10.2174/1871526519666181217120626.
7
4-Aryl-1,4-Dihydropyridines as Potential Enoyl-Acyl Carrier Protein Reductase Inhibitors: Antitubercular Activity and Molecular Docking Study.4-芳基-1,4-二氢吡啶类化合物作为潜在的烯酰基辅酶 A 还原酶抑制剂:抗结核活性及分子对接研究。
Curr Top Med Chem. 2021;21(4):295-306. doi: 10.2174/1568026620666201102121606.
8
Synthesis, molecular docking and anti-mycobacterial evaluation of new imidazo[1,2-a]pyridine-2-carboxamide derivatives.新型咪唑并[1,2-a]吡啶-2-甲酰胺衍生物的合成、分子对接及抗分枝杆菌活性评价
Eur J Med Chem. 2015 Jan 7;89:616-27. doi: 10.1016/j.ejmech.2014.10.079. Epub 2014 Oct 30.
9
Docking studies on novel alkaloid tryptanthrin and its analogues against enoyl-acyl carrier protein reductase (InhA) of Mycobacterium tuberculosis.新型生物碱靛玉红及其类似物对结核分枝杆菌烯酰-酰基载体蛋白还原酶(InhA)的对接研究。
Indian J Biochem Biophys. 2012 Dec;49(6):435-41.
10
Drug targeted virtual screening and molecular dynamics of LipU protein of Mycobacterium tuberculosis and Mycobacterium leprae.结核分枝杆菌和麻风分枝杆菌 LipU 蛋白的药物靶向虚拟筛选及分子动力学研究。
J Biomol Struct Dyn. 2019 Mar;37(5):1254-1269. doi: 10.1080/07391102.2018.1454852. Epub 2018 Mar 30.

引用本文的文献

1
Pyrrole-Based Enaminones as Building Blocks for the Synthesis of Indolizines and Pyrrolo[1,2-]pyrazines Showing Potent Antifungal Activity.基于吡咯的烯胺酮作为合成吲唑和吡咯并[1,2-a]吡嗪的构建块,表现出很强的抗真菌活性。
Molecules. 2023 Oct 23;28(20):7223. doi: 10.3390/molecules28207223.
2
Antitubercular, Cytotoxicity, and Computational Target Validation of Dihydroquinazolinone Derivatives.二氢喹唑啉酮衍生物的抗结核、细胞毒性及计算靶点验证
Antibiotics (Basel). 2022 Jun 21;11(7):831. doi: 10.3390/antibiotics11070831.
3
Progress Report: Antimicrobial Drug Discovery in the Resistance Era.

本文引用的文献

1
Synthesis and Structural Elucidation of Novel Benzothiazole Derivatives as Anti-tubercular Agents: In-silico Screening for Possible Target Identification.新型苯并噻唑衍生物作为抗结核药物的合成与结构解析:用于可能靶点识别的计算机模拟筛选
Med Chem. 2019;15(3):311-326. doi: 10.2174/1573406414666180703121815.
2
Prevalence and Molecular Characterization of Second-Line Drugs Resistance among Multidrug-Resistant Isolates in Southwest of China.中国西南部多重耐药菌株中二线药物耐药性的流行情况及分子特征
Biomed Res Int. 2017;2017:4563826. doi: 10.1155/2017/4563826. Epub 2017 Jul 17.
3
Molecular modeling studies and anti-TB activity of trisubstituted indolizine analogues; molecular docking and dynamic inputs.
进展报告:耐药时代的抗菌药物发现
Pharmaceuticals (Basel). 2022 Mar 28;15(4):413. doi: 10.3390/ph15040413.
4
Recent Developments in Free Energy Calculations for Drug Discovery.药物发现中自由能计算的最新进展。
Front Mol Biosci. 2021 Aug 11;8:712085. doi: 10.3389/fmolb.2021.712085. eCollection 2021.
5
Anti-tubercular activity and molecular docking studies of indolizine derivatives targeting mycobacterial InhA enzyme.针对分枝杆菌 InhA 酶的吲嗪衍生物的抗结核活性和分子对接研究。
J Enzyme Inhib Med Chem. 2021 Dec;36(1):1472-1487. doi: 10.1080/14756366.2021.1919889.
6
Crystallography, Molecular Modeling, and COX-2 Inhibition Studies on Indolizine Derivatives.晶态学、分子建模及 COX-2 抑制研究吲哚嗪衍生物。
Molecules. 2021 Jun 10;26(12):3550. doi: 10.3390/molecules26123550.
7
Investigation of Antifungal Properties of Synthetic Dimethyl-4-Bromo-1-(Substituted Benzoyl) Pyrrolo[1,2-a] Quinoline-2,3-Dicarboxylates Analogues: Molecular Docking Studies and Conceptual DFT-Based Chemical Reactivity Descriptors and Pharmacokinetics Evaluation.合成二甲-4-溴-1-(取代苯甲酰基)吡咯并[1,2-a]喹啉-2,3-二羧酸酯类似物的抗真菌性质研究:基于分子对接研究和基于概念 DFT 的化学反应性描述符和药代动力学评估。
Molecules. 2021 May 6;26(9):2722. doi: 10.3390/molecules26092722.
8
anti-TB properties, target validation, molecular docking and dynamics studies of substituted 1,2,4-oxadiazole analogues against .抗结核特性、靶标验证、取代 1,2,4-恶二唑类似物的分子对接和动力学研究。
J Enzyme Inhib Med Chem. 2021 Dec;36(1):869-884. doi: 10.1080/14756366.2021.1900162.
9
Anti-Tubercular Properties of 4-Amino-5-(4-Fluoro-3- Phenoxyphenyl)-4-1,2,4-Triazole-3-Thiol and Its Schiff Bases: Computational Input and Molecular Dynamics.4-氨基-5-(4-氟-3-苯氧基苯基)-4H-1,2,4-三唑-3-硫醇及其席夫碱的抗结核特性:计算输入与分子动力学
Antibiotics (Basel). 2020 Aug 31;9(9):559. doi: 10.3390/antibiotics9090559.
10
Crystallography, in Silico Studies, and In Vitro Antifungal Studies of 2,4,5 Trisubstituted 1,2,3-Triazole Analogues.2,4,5-三取代-1,2,3-三唑类似物的晶体学、计算机模拟研究及体外抗真菌研究
Antibiotics (Basel). 2020 Jun 20;9(6):350. doi: 10.3390/antibiotics9060350.
三取代吲嗪类似物的分子建模研究和抗结核活性;分子对接和动态输入。
J Biomol Struct Dyn. 2018 Jun;36(8):2163-2178. doi: 10.1080/07391102.2017.1345325. Epub 2017 Aug 14.
4
Design, synthesis, and characterization of (1-(4-aryl)- 1H-1,2,3-triazol-4-yl)methyl, substituted phenyl-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylates against Mycobacterium tuberculosis.针对结核分枝杆菌的(1-(4-芳基)-1H-1,2,3-三唑-4-基)甲基、取代苯基-6-甲基-2-氧代-1,2,3,4-四氢嘧啶-5-羧酸酯的设计、合成与表征
Drug Des Devel Ther. 2016 Aug 25;10:2681-90. doi: 10.2147/DDDT.S109760. eCollection 2016.
5
Greener synthesis of indolizine analogues using water as a base and solvent: study for larvicidal activity against Anopheles arabiensis.以水为碱和溶剂的中氮茚类似物的绿色合成:对阿拉伯按蚊的杀幼虫活性研究
Chem Biol Drug Des. 2016 Dec;88(6):899-904. doi: 10.1111/cbdd.12823. Epub 2016 Sep 9.
6
Timing is everything for compassionate use of delamanid.对于德拉马尼的同情用药而言,时机至关重要。
Nat Med. 2015 Mar;21(3):211. doi: 10.1038/nm.3823.
7
Crystal structure refinement with SHELXL.使用SHELXL进行晶体结构精修。
Acta Crystallogr C Struct Chem. 2015 Jan;71(Pt 1):3-8. doi: 10.1107/S2053229614024218. Epub 2015 Jan 1.
8
FDA approval of bedaquiline--the benefit-risk balance for drug-resistant tuberculosis.美国食品药品监督管理局批准贝达喹啉——耐多药结核病的获益-风险平衡
N Engl J Med. 2014 Aug 21;371(8):689-91. doi: 10.1056/NEJMp1314385.
9
Totally drug-resistant tuberculosis and adjunct therapies.完全耐药结核病和辅助治疗。
J Intern Med. 2015 Apr;277(4):388-405. doi: 10.1111/joim.12264. Epub 2014 Jun 18.
10
Synthesis and antitubercular activity of 2-(substituted phenyl/benzyl-amino)-6-(4-chlorophenyl)-5-(methoxycarbonyl)-4-methyl-3,6-dihydropyrimidin-1-ium chlorides.2-(取代苯基/苄基氨基)-6-(4-氯苯基)-5-(甲氧羰基)-4-甲基-3,6-二氢嘧啶-1-鎓氯化物的合成及抗结核活性。
Chem Biol Drug Des. 2013 Feb;81(2):219-27. doi: 10.1111/cbdd.12065. Epub 2012 Nov 14.